Physician profile
Ronald Frame
NPI 1609831874
$326.48
in general payments reported to CMS, 2019-2025
8 companies · $48.22 in 2025
The $48.22 reported for 2025 was less than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.32 · 2023: $125 · 2024: $135 · 2025: $48.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293 · Entertainment: $15.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.11 |
| Entertainment | $15.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $114.02 | 2023-2024 | Tyrvaya |
| Coopervision INC. | $52.12 | 2023-2025 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $46.99 | 2024-2025 | Infuse, Biotrue One Day |
| Alcon Vision LLC | $29.08 | 2023 | Precision 1 |
| Tarsus Pharmaceuticals, INC. | $28.47 | 2024 | Xdemvy |
| Thea Pharma INC. | $22.43 | 2024 | Iyuzeh |
| Johnson & Johnson Vision Care, INC. | $18.32 | 2021 | |
| Optos, INC. | $15.05 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Frame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.